Unlocking the potential of biosimilars for more sustainable care
Biopharmaceutical drugs hold transformative potential. Since they first emerged in the 1980s, biopharmaceutical drugs, or biologics, have made a significant impact on treatment for patients suffering from debilitating conditions in immunology, ophthalmology and oncology, among many other disease areas. While pain, progressive disability and the loss of ability to work are par for the course […]
Continue Reading